As a heart specialist, Dr. Califf spent many years main scientific trials on the Duke University Medical Center in North Carolina. Most lately, he led scientific coverage and technique for Verily, the life sciences arm at Alphabet, the father or mother firm of Google. During the listening to, he emphasised the worth of current knowledge, a lot in sufferers’ digital medical information, to assist reply troublesome questions concerning the proof for medicine and units.
Republicans requested how he would deal with guidelines round medicines to induce abortion, which had been relaxed through the pandemic after years of tight restrictions. Two days after the listening to, the F.D.A. — underneath Dr. Janet Woodcock, the interim commissioner — introduced that it might completely elevate restrictions, permitting sufferers to terminate a being pregnant within the first 10 weeks after a telemedicine go to with medicines taken at dwelling.
Senator Tommy Tuberville, a Republican committee member from Alabama, mentioned in an announcement that the latest determination knowledgeable his committee vote. “I believe Dr. Califf will continue to advance this administration’s pro-abortion agenda, and I cannot support his nomination,” he mentioned.
Senator Mike Braun, a Republican from Indiana, additionally mentioned he opposed the nomination over abortion insurance policies and opioid issues. “Under his leadership in 2016, the F.D.A. expanded access to the dangerous chemical abortion drug mifepristone and failed to take action to stem the tide of the opioid crisis ravaging our country,” he mentioned in an announcement.
Dr. Califf was beforehand confirmed in a 89-to-4 Senate vote to guide the F.D.A. over the last 12 months of the Obama administration. If confirmed once more, he’ll face key choices on tobacco management as he tries to steadiness e-cigarettes as a software to assist some give up smoking with out creating a brand new technology of customers. Scrutiny round accelerated approvals of medicine might be heightened, given the present debate over the company’s approval of the controversial Alzheimer’s drug Aduhelm.
After Senator Sanders denounced Dr. Califf’s ties to pharmaceutical corporations, which embody consulting charges and inventory possession amounting to as a lot as $8 million, the nominee advised the Senate panel in mid-December that he would adjust to ethics guidelines set by the F.D.A. and its father or mother company, the Department of Health and Human Services.
Senator Hassan of New Hampshire additionally voted in opposition to Dr. Califf’s nomination. She had pressed him in December on the F.D.A.’s failure to replace the labeling of opioid medicines. Dr. Califf mentioned the company would proceed to assessment the proof coming in.